ArticleJournal of translational medicine2020

Safety, tolerability and immunogenicity of V934/V935 hTERT vaccination in cancer patients with selected solid tumors: a phase I study.

Luigi Aurisicchio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.